
Cipla Limited has informed the Exchange regarding a press release dated December 18, 2021, titled "Cipla Receives Final Approval for Lanreotide Injection".
Filed with NSE ·

Cipla Limited has informed the Exchange regarding a press release dated December 18, 2021, titled "Cipla Receives Final Approval for Lanreotide Injection".
6ix hasn’t read this filing yet.
Follow Cipla into a list and get an email when it puts out news.
Follow Cipla